Category: Editors’ Pick

Digital Health’s Latest Unicorn Aims To Lower Employee Drug Costs

Rightway raised $100 million at a valuation of $1.1 billion for its navigation platform combined with a next generation pharmacy benefits manager.

‘Nobody Is Safe Until Everyone Is Safe’: World Leaders Call For Global Pandemic Preparedness Treaty

Some 23 countries and the WHO signed on, though China and the U.S. are notably absent.

Cityblock Health Gets $192 Million Funding Boost To Turbocharge Care For Low-Income Patients

The digital health unicorn is taking on the Medicaid market and betting its community-based model can keep members healthier while lowering costs.

Nasal Spray Of Covid Vaccine May Be Next: Oxford Reportedly To Test AstraZeneca Version

Nasal spray vaccines are easier to administer, avoid needles and can even provide better protection against infection.

Tokyo 2020 Olympic Torch Relay Finally Begins After Year-Long Covid-19 Delay

Officials hope the relay will soften opposition to the Olympic Games, which many in Japan oppose in light of the ongoing pandemic.

What’s Next For Moderna Post-Covid-19: CEO Stephane Bancel Details mRNA Pipeline

One of the world’s first mRNA vaccines made Bancel a billionaire—and now the biotech CEO discusses his plans to use the mRNA breakthrough for cancer, genetic disorders, and even a better flu vaccine.

Virtual Reality Startup Raises $29 Million To Help With Chronic Pain

Virtual reality therapeutics could help fight the opioid addiction crisis in America, says, Matthew Stoudt, co-founder, AppliedVR

Digital Health Startup Ro Raised $500 Million At $5 Billion Valuation

The cash pay company looks to offer a full stack primary care solution in lieu of traditional health insurance, including pharmacy distribution and in-home diagnostics.

European Trust In AstraZeneca’s Covid-19 Shot Plummets Amid Politicized Blood Clot Scare

There were no similar surge in vaccine fears for shots by Pfizer and Moderna.

Europe’s Flip-Flopping Over AstraZeneca’s Covid-19 Vaccine Continues: France Ignores Regulator And Limits Shot To Over-55s

France has changed its guidance on the shot three, initially restricting it to those under 65 years of age.